Anthony Morlandt
Program Director · University of Alabama Hospital
Credentials: · · · ·
History
- 2007–2010
Residency
Research
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
Clinical Cancer Research · 2015 · 390 citations
JAMA Otolaryngology–Head & Neck Surgery · 2015 · 121 citations
Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions
Review · The Laryngoscope · 2020 · 79 citations
16 papers
14 papers · 14 as a resident
12 papers
9 papers
7 papers
5 papers · 4 as a resident
5 papers
4 papers
Clinical trials
- 2021–2030
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
Principal investigator · Recruiting · Phase 2
University of Alabama at Birmingham
- 2020–2022
Regional Block for Postoperative Free Flap Care
Principal investigator · Completed · Phase 4
University of Alabama at Birmingham